Stock Analysis
- Australia
- /
- Life Sciences
- /
- ASX:TRJ
Trajan Group Holdings Full Year 2024 Earnings: EPS Misses Expectations
Trajan Group Holdings (ASX:TRJ) Full Year 2024 Results
Key Financial Results
- Revenue: AU$155.0m (down 4.4% from FY 2023).
- Net loss: AU$25.3m (down from AU$1.89m profit in FY 2023).
- AU$0.17 loss per share (down from AU$0.012 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Trajan Group Holdings EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Global Life Sciences industry.
Performance of the market in Australia.
The company's share price is broadly unchanged from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Trajan Group Holdings' balance sheet.
Valuation is complex, but we're here to simplify it.
Discover if Trajan Group Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:TRJ
Trajan Group Holdings
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.